市場調查報告書

腎上腺素自動注射器

Epinephrine Auto-injector

出版商 Global Industry Analysts, Inc. 商品編碼 938946
出版日期 內容資訊 英文 176 Pages
商品交期: 最快1-2個工作天內
價格
腎上腺素自動注射器 Epinephrine Auto-injector
出版日期: 2020年07月01日內容資訊: 英文 176 Pages
簡介

在COVID-19造成的危機和即將到來的經濟不景氣下,全球腎上腺素自動注射器市場在預測期間內將以5.6%成長。注射液0.15gm區隔預計將成長6%以上,預計在預測期間末達到19億美元。在新方案中,美國的年複合成長率已修改為6.6%。日本的注射液0.15gm區隔,預計在預測期間末達到1億3120萬美元。

本報告提供全球腎上腺素自動注射器市場相關調查,市場概要,COVID-19帶來的影響,各地區、國家的分析與預測,及主要企業的簡介等系統性資訊。

第1部分 簡介、調查手法、調查範圍

第2部分 摘要整理

第1章 市場概要

  • 全球競爭企業的市場佔有率
  • 競爭企業的市場佔有率方案
  • Covid-19的影響和即將到來的全球經濟不景氣

第2章 主要企業

第3章 市場趨勢、促進因素

第4章 全球市場預測

第3部分 市場分析

  • 各地區市場分析
  • 美國
    • 市場資料
    • 美國的腎上腺素自動注射器的市場佔有率,各企業
    • 市場分析
  • 加拿大
  • 日本
  • 中國
  • 歐洲
    • 市場資料
    • 競爭企業的市場佔有率方案
    • 市場分析
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲
  • 其他

第4部分 競爭

  • 企業簡介
目錄
Product Code: MCP11840

Global Epinephrine Auto-injector Market to Reach $2.7 Billion by 2027

Amid the COVID-19 crisis, the global market for Epinephrine Auto-injector estimated at US$1.8 Billion in the year 2020, is projected to reach a revised size of US$2.7 Billion by 2027, growing at a CAGR of 5.6% over the analysis period 2020-2027. 0.15gm Dosage, one of the segments analyzed in the report, is projected to record a 6% CAGR and reach US$1.9 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the 0.30gm Dosage segment is readjusted to a revised 5.1% CAGR for the next 7-year period.

The U.S. Market is Estimated at $535 Million, While China is Forecast to Grow at 5.2% CAGR

The Epinephrine Auto-injector market in the U.S. is estimated at US$535 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$467.1 Million by the year 2027 trailing a CAGR of 5.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.3% and 4.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.6% CAGR.

0.5gm Dosage Segment to Record 3.5% CAGR

In the global 0.5gm Dosage segment, USA, Canada, Japan, China and Europe will drive the 3.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$108.9 Million in the year 2020 will reach a projected size of US$138.9 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$304.9 Million by the year 2027.We bring years of research experience to this 7th edition of our report. The 176-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • Adamis Pharmaceuticals Corporation
  • ALK-Abello AS
  • Antares Pharma, Inc.
  • Bausch + Lomb UK Ltd- Emerade
  • Hospira, Inc.
  • Impax Laboratories, Inc.
  • Lincoln Medical
  • Mylan N.V.
  • Teva Pharmaceutical Industries Ltd.

TABLE OF CONTENTS

  • I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • Epinephrine Autoinjector Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Epinephrine Auto-injector Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020-2027
  • TABLE 2: Epinephrine Auto-injector Global Retrospective Market Scenario in US$ Thousand by Region/Country: 2012-2019
  • TABLE 3: Epinephrine Auto-injector Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027
  • TABLE 4: 0.15gm Dosage (Dosage) World Market by Region/Country in US$ Thousand: 2020 to 2027
  • TABLE 5: 0.15gm Dosage (Dosage) Historic Market Analysis by Region/Country in US$ Thousand: 2012 to 2019
  • TABLE 6: 0.15gm Dosage (Dosage) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 7: 0.30gm Dosage (Dosage) Potential Growth Markets Worldwide in US$ Thousand: 2020 to 2027
  • TABLE 8: 0.30gm Dosage (Dosage) Historic Market Perspective by Region/Country in US$ Thousand: 2012 to 2019
  • TABLE 9: 0.30gm Dosage (Dosage) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027
  • TABLE 10: 0.5gm Dosage (Dosage) Geographic Market Spread Worldwide in US$ Thousand: 2020 to 2027
  • TABLE 11: 0.5gm Dosage (Dosage) Region Wise Breakdown of Global Historic Demand in US$ Thousand: 2012 to 2019
  • TABLE 12: 0.5gm Dosage (Dosage) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 13: Hospitals & Clinics (End-Use) Demand Potential Worldwide in US$ Thousand by Region/Country: 2020-2027
  • TABLE 14: Hospitals & Clinics (End-Use) Historic Sales Analysis in US$ Thousand by Region/Country: 2012-2019
  • TABLE 15: Hospitals & Clinics (End-Use) Share Breakdown Review by Region/Country:
  • 2012 VS 2020 VS 2027
    • TABLE 16: Individuals (End-Use) Worldwide Latent Demand Forecasts in US$ Thousand by Region/Country: 2020-2027
    • TABLE 17: Individuals (End-Use) Global Historic Analysis in US$ Thousand by Region/Country: 2012-2019
    • TABLE 18: Individuals (End-Use) Distribution of Global Sales by Region/Country:
  • 2012 VS 2020 VS 2027

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Epinephrine Autoinjector Market Share (in %) by Company: 2019 & 2025
    • Market Analytics
    • TABLE 19: United States Epinephrine Auto-injector Market Estimates and Projections in US$ Thousand by Dosage: 2020 to 2027
    • TABLE 20: Epinephrine Auto-injector Market in the United States by Dosage: A Historic Review in US$ Thousand for 2012-2019
    • TABLE 21: United States Epinephrine Auto-injector Market Share Breakdown by Dosage: 2012 VS 2020 VS 2027
    • TABLE 22: United States Epinephrine Auto-injector Latent Demand Forecasts in US$ Thousand by End-Use: 2020 to 2027
    • TABLE 23: Epinephrine Auto-injector Historic Demand Patterns in the United States by End-Use in US$ Thousand for 2012-2019
    • TABLE 24: Epinephrine Auto-injector Market Share Breakdown in the United States by End-Use: 2012 VS 2020 VS 2027
  • CANADA
    • TABLE 25: Canadian Epinephrine Auto-injector Market Estimates and Forecasts in US$ Thousand by Dosage: 2020 to 2027
    • TABLE 26: Canadian Epinephrine Auto-injector Historic Market Review by Dosage in US$ Thousand: 2012-2019
    • TABLE 27: Epinephrine Auto-injector Market in Canada: Percentage Share Breakdown of Sales by Dosage for 2012, 2020, and 2027
    • TABLE 28: Canadian Epinephrine Auto-injector Market Quantitative Demand Analysis in US$ Thousand by End-Use: 2020 to 2027
    • TABLE 29: Epinephrine Auto-injector Market in Canada: Summarization of Historic Demand Patterns in US$ Thousand by End-Use for 2012-2019
    • TABLE 30: Canadian Epinephrine Auto-injector Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
  • JAPAN
    • TABLE 31: Japanese Market for Epinephrine Auto-injector: Annual Sales Estimates and Projections in US$ Thousand by Dosage for the Period 2020-2027
    • TABLE 32: Epinephrine Auto-injector Market in Japan: Historic Sales Analysis in US$ Thousand by Dosage for the Period 2012-2019
    • TABLE 33: Japanese Epinephrine Auto-injector Market Share Analysis by Dosage: 2012 VS 2020 VS 2027
    • TABLE 34: Japanese Demand Estimates and Forecasts for Epinephrine Auto-injector in US$ Thousand by End-Use: 2020 to 2027
    • TABLE 35: Japanese Epinephrine Auto-injector Market in US$ Thousand by End-Use: 2012-2019
    • TABLE 36: Epinephrine Auto-injector Market Share Shift in Japan by End-Use: 2012 VS 2020 VS 2027
  • CHINA
    • TABLE 37: Chinese Epinephrine Auto-injector Market Growth Prospects in US$ Thousand by Dosage for the Period 2020-2027
    • TABLE 38: Epinephrine Auto-injector Historic Market Analysis in China in US$ Thousand by Dosage: 2012-2019
    • TABLE 39: Chinese Epinephrine Auto-injector Market by Dosage: Percentage Breakdown of Sales for 2012, 2020, and 2027
    • TABLE 40: Chinese Demand for Epinephrine Auto-injector in US$ Thousand by End-Use: 2020 to 2027
    • TABLE 41: Epinephrine Auto-injector Market Review in China in US$ Thousand by End-Use: 2012-2019
    • TABLE 42: Chinese Epinephrine Auto-injector Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027
  • EUROPE
    • Market Facts & Figures
    • European Epinephrine Autoinjector Market: Competitor Market Share Scenario (in %)
    • for 2019 & 2025
    • Market Analytics
    • TABLE 43: European Epinephrine Auto-injector Market Demand Scenario in US$ Thousand by Region/Country: 2020-2027
    • TABLE 44: Epinephrine Auto-injector Market in Europe: A Historic Market Perspective in US$ Thousand by Region/Country for the Period 2012-2019
    • TABLE 45: European Epinephrine Auto-injector Market Share Shift by Region/Country: 2012 VS 2020 VS 2027
    • TABLE 46: European Epinephrine Auto-injector Market Estimates and Forecasts in US$ Thousand by Dosage: 2020-2027
    • TABLE 47: Epinephrine Auto-injector Market in Europe in US$ Thousand by Dosage: A Historic Review for the Period 2012-2019
    • TABLE 48: European Epinephrine Auto-injector Market Share Breakdown by Dosage: 2012 VS 2020 VS 2027
    • TABLE 49: European Epinephrine Auto-injector Addressable Market Opportunity in US$ Thousand by End-Use: 2020-2027
    • TABLE 50: Epinephrine Auto-injector Market in Europe: Summarization of Historic Demand in US$ Thousand by End-Use for the Period 2012-2019
    • TABLE 51: European Epinephrine Auto-injector Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
  • FRANCE
    • TABLE 52: Epinephrine Auto-injector Market in France by Dosage: Estimates and Projections in US$ Thousand for the Period 2020-2027
    • TABLE 53: French Epinephrine Auto-injector Historic Market Scenario in US$ Thousand by Dosage: 2012-2019
    • TABLE 54: French Epinephrine Auto-injector Market Share Analysis by Dosage: 2012 VS 2020 VS 2027
    • TABLE 55: Epinephrine Auto-injector Quantitative Demand Analysis in France in US$ Thousand by End-Use: 2020-2027
    • TABLE 56: French Epinephrine Auto-injector Historic Market Review in US$ Thousand by End-Use: 2012-2019
    • TABLE 57: French Epinephrine Auto-injector Market Share Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and 2027
  • GERMANY
    • TABLE 58: Epinephrine Auto-injector Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Dosage for the Period 2020-2027
    • TABLE 59: German Epinephrine Auto-injector Historic Market Analysis in US$ Thousand by Dosage: 2012-2019
    • TABLE 60: German Epinephrine Auto-injector Market Share Breakdown by Dosage: 2012 VS 2020 VS 2027
    • TABLE 61: Epinephrine Auto-injector Market in Germany: Annual Sales Estimates and Forecasts in US$ Thousand by End-Use for the Period 2020-2027
    • TABLE 62: German Epinephrine Auto-injector Market in Retrospect in US$ Thousand by End-Use: 2012-2019
    • TABLE 63: Epinephrine Auto-injector Market Share Distribution in Germany by End-Use:
  • 2012 VS 2020 VS 2027
  • ITALY
    • TABLE 64: Italian Epinephrine Auto-injector Market Growth Prospects in US$ Thousand by Dosage for the Period 2020-2027
    • TABLE 65: Epinephrine Auto-injector Historic Market Analysis in Italy in US$ Thousand by Dosage: 2012-2019
    • TABLE 66: Italian Epinephrine Auto-injector Market by Dosage: Percentage Breakdown of Sales for 2012, 2020, and 2027
    • TABLE 67: Italian Demand for Epinephrine Auto-injector in US$ Thousand by End-Use: 2020 to 2027
    • TABLE 68: Epinephrine Auto-injector Market Review in Italy in US$ Thousand by End-Use: 2012-2019
    • TABLE 69: Italian Epinephrine Auto-injector Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027
  • UNITED KINGDOM
    • TABLE 70: United Kingdom Market for Epinephrine Auto-injector: Annual Sales Estimates and Projections in US$ Thousand by Dosage for the Period 2020-2027
    • TABLE 71: Epinephrine Auto-injector Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Dosage for the Period 2012-2019
    • TABLE 72: United Kingdom Epinephrine Auto-injector Market Share Analysis by Dosage: 2012 VS 2020 VS 2027
    • TABLE 73: United Kingdom Demand Estimates and Forecasts for Epinephrine Auto-injector in US$ Thousand by End-Use: 2020 to 2027
    • TABLE 74: United Kingdom Epinephrine Auto-injector Market in US$ Thousand by End-Use: 2012-2019
    • TABLE 75: Epinephrine Auto-injector Market Share Shift in the United Kingdom by End-Use: 2012 VS 2020 VS 2027
  • REST OF EUROPE
    • TABLE 76: Rest of Europe Epinephrine Auto-injector Market Estimates and Forecasts in US$ Thousand by Dosage: 2020-2027
    • TABLE 77: Epinephrine Auto-injector Market in Rest of Europe in US$ Thousand by Dosage: A Historic Review for the Period 2012-2019
    • TABLE 78: Rest of Europe Epinephrine Auto-injector Market Share Breakdown by Dosage: 2012 VS 2020 VS 2027
    • TABLE 79: Rest of Europe Epinephrine Auto-injector Addressable Market Opportunity in US$ Thousand by End-Use: 2020-2027
    • TABLE 80: Epinephrine Auto-injector Market in Rest of Europe: Summarization of Historic Demand in US$ Thousand by End-Use for the Period 2012-2019
    • TABLE 81: Rest of Europe Epinephrine Auto-injector Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
  • ASIA-PACIFIC
    • TABLE 82: Epinephrine Auto-injector Market in Asia-Pacific by Dosage: Estimates and Projections in US$ Thousand for the Period 2020-2027
    • TABLE 83: Asia-Pacific Epinephrine Auto-injector Historic Market Scenario in US$ Thousand by Dosage: 2012-2019
    • TABLE 84: Asia-Pacific Epinephrine Auto-injector Market Share Analysis by Dosage: 2012 VS 2020 VS 2027
    • TABLE 85: Epinephrine Auto-injector Quantitative Demand Analysis in Asia-Pacific in US$ Thousand by End-Use: 2020-2027
    • TABLE 86: Asia-Pacific Epinephrine Auto-injector Historic Market Review in US$ Thousand by End-Use: 2012-2019
    • TABLE 87: Asia-Pacific Epinephrine Auto-injector Market Share Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and 2027
  • REST OF WORLD
    • TABLE 88: Rest of World Epinephrine Auto-injector Market Estimates and Forecasts in US$ Thousand by Dosage: 2020 to 2027
    • TABLE 89: Rest of World Epinephrine Auto-injector Historic Market Review by Dosage in US$ Thousand: 2012-2019
    • TABLE 90: Epinephrine Auto-injector Market in Rest of World: Percentage Share Breakdown of Sales by Dosage for 2012, 2020, and 2027
    • TABLE 91: Rest of World Epinephrine Auto-injector Market Quantitative Demand Analysis in US$ Thousand by End-Use: 2020 to 2027
    • TABLE 92: Epinephrine Auto-injector Market in Rest of World: Summarization of Historic Demand Patterns in US$ Thousand by End-Use for 2012-2019
    • TABLE 93: Rest of World Epinephrine Auto-injector Market Share Analysis by End-Use: 2012 VS 2020 VS 2027

IV. COMPETITION

  • Total Companies Profiled: 44